Opinion|Videos|November 10, 2023
Achieving Superior Treatment Durability and Outcomes In Neovascular AMD and DME
Expert retina specialists discuss the latest therapies that could reduce the treatment burden and provide superior clinical outcomes in retinal diseases.
Advertisement
0:00 Introduction
0:56 Need for durable treatments in nAMD and DME
4:29 Mechanism of faricimab
7:14 Highlights from clinical trials for faricimab
10:33 Post hoc analyses of faricimab clinical trials
16:24 Factors affecting retreatment decision
19:28 Durability data for faricimab
23:22 Experience with faricimab
29:06 Choosing between faricimab and high-dose aflibercept
32:51 Final remarks
Advertisement
Related to this article
The plasmid DNA immunotherapy Voceryq gained FDA accelerated approval after 27% of RRP-001 patients needed no surgery for 12 months.
IgAN late-breakers led the meeting, alongside new data on aspirin, dialysis access, donor pregnancy, potassium, and depression.
Experts discuss remibrutinib, the first FDA-approved therapy for symptomatic dermographism: RemIND data, bleeding counseling, and where it fits in practice
Five liver societies define ACLF as liver failure plus extrahepatic organ dysfunction or failure, with three grades and FDA-informed trial endpoints.
Five CHEST 2026 interviews cover nalbuphine ER for IPF cough, tozorakimab in COPD, depemokimab remission, AD109 in OSA, and robotic bronchoscopy.
Psoriasis advocates Nitika Chopra and Ayesha Patrick address common misconceptions, how patients can speak up, and simple tips for clinicians.
The FDA has pushed its decision on mitapivat for sickle cell disease to February 1, 2027, while it reviews updated safety data to decide whether a REMS is needed.
Lindsay Ackerman, MD, and Chris Bunick, MD, PhD, examine how ORAL Surveillance shaped JAK warnings and what long-term atopic dermatitis data show.
Advertisement
Advertisement
Trending on HCPLive
1
Nalbuphine ER Rapidly Eases IPF Cough Burden, With Phil Molyneaux, MD, PhD
2
Voceryq Gains FDA Accelerated Approval for Recurrent Respiratory Papillomatosis
3
Sarcoidosis Care Starts With Inflammation vs Fibrosis: Rohit Gupta, MD
4
HCPLive Five at CHEST 2026
5